These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22174824)

  • 1. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
    Zhang L; Yuan Y; Lu KH; Zhang L
    BMC Bioinformatics; 2016 May; 17(1):222. PubMed ID: 27230211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative epigenomic and genomic analysis of malignant pheochromocytoma.
    Sandgren J; Andersson R; Rada-Iglesias A; Enroth S; Akerstrom G; Dumanski JP; Komorowski J; Westin G; Wadelius C
    Exp Mol Med; 2010 Jul; 42(7):484-502. PubMed ID: 20534969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of significant aberrations in cancer genome.
    Yuan X; Yu G; Hou X; Shih IeM; Clarke R; Zhang J; Hoffman EP; Wang RR; Zhang Z; Wang Y
    BMC Genomics; 2012 Jul; 13():342. PubMed ID: 22839576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-score: a scoring system for the identification and prioritization of predicted cancer genes.
    de Souza JE; Fonseca AF; Valieris R; Carraro DM; Wang JY; Kolodner RD; de Souza SJ
    PLoS One; 2014; 9(4):e94147. PubMed ID: 24710071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative network analysis of TCGA data for ovarian cancer.
    Zhang Q; Burdette JE; Wang JP
    BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cancer-associated genes in ovarian cancer.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.
    Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X
    PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
    Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
    Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer.
    Laudański P; Kowalczuk O; Klasa-Mazurkiewicz D; Milczek T; Rysak-Luberowicz D; Garbowicz M; Baranowski W; Charkiewicz R; Szamatowicz J; Chyczewski L
    Folia Histochem Cytobiol; 2011; 49(2):317-24. PubMed ID: 21744334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.
    Fonti C; Saumet A; Abi-Khalil A; Orsetti B; Cleroux E; Bender A; Dumas M; Schmitt E; Colinge J; Jacot W; Weber M; Sardet C; du Manoir S; Theillet C
    Int J Cancer; 2019 Sep; 145(5):1299-1311. PubMed ID: 31093963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition.
    Fejzo MS; Chen HW; Anderson L; McDermott MS; Karlan B; Konecny GE; Slamon DJ
    Gynecol Oncol; 2021 Feb; 160(2):539-546. PubMed ID: 33229045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
    Davis SJ; Choong DY; Ramakrishna M; Ryland GL; Campbell IG; Gorringe KL
    BMC Cancer; 2011 May; 11():173. PubMed ID: 21575258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.